Nicholas Hoffman & Company’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Hold
1,585
0.01% 271
2026
Q1
$335K Hold
1,585
0.01% 274
2025
Q4
$326K Hold
1,585
0.01% 268
2025
Q3
$249K Sell
1,585
-26
-2% -$4.02K 0.01% 284
2025
Q2
$271K Buy
+1,611
New +$239K 0.01% 268
2022
Q4
Sell
-14,648
Closed -$977K 265
2022
Q3
$977K Buy
14,648
+108
+0.7% +$6.85K 0.05% 107
2022
Q2
$760K Buy
14,540
+1,195
+9% +$67.9K 0.04% 128
2022
Q1
$757K Buy
+13,345
New +$715K 0.03% 134
2018
Q4
Sell
-3,780
Closed -$204K 183
2018
Q3
$204K Buy
+3,780
New +$193K 0.07% 182

Other funds holding CAH

Nicholas Hoffman & Company's CAH Position: Q2 2026 in Review

Nicholas Hoffman & Company held its Cardinal Health (CAH) position steady in Q2 2026 at 1,585 shares worth $377K. The position accounts for 0.01% of the portfolio, ranked #271.

Nicholas Hoffman & Company first reported a position in CAH in Q3 2018 and has held it in 9 quarters since. The position peaked at $977K in Q3 2022. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Nicholas Hoffman & Company held 1,585 shares of Cardinal Health worth $377K as of Q2 2026.
  • Nicholas Hoffman & Company left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up 0.01% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #271 holding.
  • Nicholas Hoffman & Company first reported a position in Cardinal Health in Q3 2018 and has held it in 9 quarters since.
  • Nicholas Hoffman & Company's Cardinal Health position peaked at $977K in Q3 2022.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.